Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metronomic chemotherapy for advanced breast cancer patients.
Cazzaniga ME, Dionisio MR, Riva F. Cazzaniga ME, et al. Among authors: riva f. Cancer Lett. 2017 Aug 1;400:252-258. doi: 10.1016/j.canlet.2016.12.019. Epub 2016 Dec 23. Cancer Lett. 2017. PMID: 28017894 Review.
Metronomic Chemotherapy.
Cazzaniga ME, Cordani N, Capici S, Cogliati V, Riva F, Cerrito MG. Cazzaniga ME, et al. Among authors: riva f. Cancers (Basel). 2021 May 6;13(9):2236. doi: 10.3390/cancers13092236. Cancers (Basel). 2021. PMID: 34066606 Free PMC article. Review.
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study.
Pepe FF, Cazzaniga ME, Baroni S, Riva F, Cicchiello F, Capici S, Cogliati V, Maggioni C, Cordani N, Cerrito MG, Malandrin S. Pepe FF, et al. Among authors: riva f. BMC Cancer. 2022 Sep 6;22(1):956. doi: 10.1186/s12885-022-10031-6. BMC Cancer. 2022. PMID: 36068484 Free PMC article. Clinical Trial.
368 results